Izraelis - hebrajų - Ministry of Health

ג'ויה מעבדות לקוסמטיקה בעמ - טיפול בקשקשים

Izraelis - hebrajų - Ministry of Health

פישר מעבדות פרמצבטיות בעמ - רענון הגוף

Izraelis - hebrajų - Ministry of Health

פישר מעבדות פרמצבטיות בעמ - מניעת זיעה וריח הנובע מכך

Izraelis - hebrajų - Ministry of Health

פישר מעבדות פרמצבטיות בעמ - קרם ידיים

Izraelis - hebrajų - Ministry of Health

dr.samuelov importing & marketing ltd, israel - pelargonium sidoides roots (1: 8- 10) (eps® 7630) dried liquid extract; extracting agent : ethanol 11% (w/w) - טבליות מצופות פילם - pelargonium sidoides roots (1: 8- 10) (eps® 7630) dried liquid extract; extracting agent : ethanol 11% (w/w) 20 mg - cough suppressants and mucolytics

Izraelis - hebrajų - Ministry of Health

dr.samuelov importing & marketing ltd, israel - pelargonium sidoides roots (1: 8- 10) (eps® 7630) dried liquid extract; extracting agent : ethanol 11% (w/w) - סירופ - pelargonium sidoides roots (1: 8- 10) (eps® 7630) dried liquid extract; extracting agent : ethanol 11% (w/w) 20 mg / 7.5 ml - cough suppressants and mucolytics

Izraelis - hebrajų - Ministry of Health

padagis israel agencies ltd, israel - tetanus immune globulin (s/d treated) - תמיסה להזרקה - tetanus immune globulin (s/d treated) 250 u/ml - tetanus immunoglobulin - tetanus immunoglobulin - immunity against tetanus toxin. treatment of active cases of tetanus.

Izraelis - hebrajų - Ministry of Health

dexcel pharma technologies ltd - clopidogrel as besylate - טבליות מצופות פילם - clopidogrel as besylate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows:• recent mi, recent stroke or established peripheral arterial disease: patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. for patients with a history of recent myocardial infarction (mi), recent stroke or established peripheral arterial disease, clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new mi (fatal or not) and other vascular death.• acute coronary syndrome: for patients with acute coronary syndrome (non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction), in combination with asa in medically treated patients eligible for thrombolytic therapy, and those who are to be managed with percutaneous coronary intervention (with or without stent) or cabg clopi

Izraelis - hebrajų - Ministry of Health

medomie pharma ltd, israel - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate

Izraelis - hebrajų - Ministry of Health

medomie pharma ltd, israel - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate